Results 271 to 280 of about 338,185 (301)

Repurposed drugs for treatment against COVID-19

Everyman's Science, 2023
COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a dreaded disease because of its high transmissibility through direct contact or by droplets. Reducing the transmission and saving the human lives by curtailing the death rate are the major concerns in the prevailing situation.
Ramendra K. Singh, null Rupa Raj, null Jayati Dwivedi, null Vishal K. Singh   +3 more
openaire   +1 more source

Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review

Current Pharmaceutical Design, 2021
Background: The rapid eruption of Coronavirus at the end of 2019 has caused global health crisis and significant loss to the economy and social well-being. This created a massive shortage of advanced health facilities with inadequate medicinal supply, further deteriorating human health conditions.
Meenakshi, Singh, Darshini, Trivedi, Reecha, Mohapatra, Trisha, Bagchi, Chandrasai P, Durthi, Chandrasekhar, Kuppam   +5 more
openaire   +2 more sources

Drugs for the Treatment of COVID-19

2021
Currently, there are no drugs or other therapeutic agents approved by the U.S. Food and Drug Administration (FDA) to prevent or treat COVID-19. Current standard of care includes prevention of infection and control measures and supportive care, including supplemental oxygen and, when required, mechanical ventilatory support.
Sagheer Ahmed, Halimur Rehman, Rehan Salar, May Nasser Bin-Jumah, M. Tauseef Sultan, Marius Moga   +5 more
openaire   +1 more source

Drug treatment of coronavirus disease COVID-19: evidence exists?

Khirurgiya. Zhurnal im. N.I. Pirogova, 2020
The article provides a review of foreign literature for 2020 on existing methods of drug treatment of coronavirus disease COVID-19. To date, in the treatment of COVID-19 in different countries, a little more than 10 drugs are used. The largest number of studies on the testing of these drugs is carried out by scientists from China, the USA, and European
Sh V, Timerbulatov, M V, Timerbulstov, E N, Gainullina, A R, Gafarova, V M, Timerbulatov   +4 more
openaire   +2 more sources

COVID-19 drug discovery and treatment options

Nature Reviews Microbiology
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and mortality, and serious social and economic disruptions worldwide. Unvaccinated or incompletely vaccinated older individuals with underlying diseases are especially prone to severe disease.
Jasper Fuk-Woo Chan, Shuofeng Yuan, Hin Chu, Siddharth Sridhar, Kwok-Yung Yuen   +4 more
openaire   +2 more sources

COVID-19 Pathophysiology, Clinical Manifestations, and Drug Treatment

2022
COVID-19 is caused by a single-stranded RNA encapsulated betacoronavirus, known as SARS-CoV-2, implicated in the pandemic that started in China in 2019. Viral replication consists of five stages that culminate in the release of the new virion. The exaggerated inflammatory response of COVID-19 is characterized by an elevation of acute phase reactants ...
Daniel Manzur Sandoval, Gustavo Rojas-Velasco, Efren Melano Carranza, Camelia Cruz Rodr´ıguez, Arturo Arzate Ram´ırez, Francisco J avier Gonzalez Ruiz, Gerardo Arteaga Cardenas, Mar´ıa Alexandra Lopez Polanco, Eduardo Alberto Gonzalez Escudero, Edgar Garc´ıa Cruz, Luis Augusto Baeza Herrera, Luis Efren Santos Mart´ınez   +11 more
openaire   +1 more source

Effects of antiviral drugs on COVID-19 treatment

Discrete and Continuous Dynamical Systems - B
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Luo, Min, Jia, Junbo, Wang, Ruiqi, Wang, Lin   +3 more
openaire   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino, Roberto Carmagnani Pestana, Shanu Modi   +2 more
exaly